KULR Technology Group reported a 197% year-over-year revenue increase to $7.4 million in Q3 2026, fueled by a 299% rise in product sales, mainly from its KULR ONE battery platform. The company completed its exit from Bitcoin mining, ending the quarter with $54.5 million in cash and no debt. Despite a 4% gross margin and increased R&D expenses, KULR is focusing on cost reductions and scaling battery production in 2027, targeting growth in autonomous systems and energy storage markets, especially in Japan. The company expects to improve profitability by streamlining operations and expanding its NDAA-compliant battery supply chain.
KULR Technology Group's Q3 2026 revenue growth provides context for technology sector performance. As of Nov 10, 2026 19:03 WIB, among 150 priced US technology stocks on Pluang, 45 rose and 99 fell. Notable movers include QUBT at USD 6.58 with a 4.08% decline and 98% sell activity, TTWO at USD 215.26 up 3.79% with 55% buy activity, and YOU at USD 56.86 up 3.21% with 100% sell activity.
project44 has partnered with Snowflake to enhance supply chain decision-making through Mo, an AI-powered supply chain analyst. Mo uses project44's extensive logistics data and Snowflake Cortex AI to provide accurate, consistent answers to complex sup...
H&R Block has launched the Emerald Advance Loan, a fixed-rate short-term loan up to $1,750 with a 35.90% APR, designed to help families cover year-end expenses without monthly payments. Borrowers repay the loan in full by March 31, 2027, with no impa...
Duke Robotics has entered a strategic collaboration with Greek security firm CRONOS to commercialize its Insulator Cleaning Drone (IC Drone) technology in Greece. This partnership leverages CRONOS's strong presence in Greece's critical infrastructure...
Alm. Brand A/S repurchased 1,369,397 shares between November 3 and 9, 2026, at an average price of DKK 17.46 per share. This is part of their announced buy-back program totaling up to DKK 593 million, aiming to reduce the number of outstanding shares...
Novartis has secured first place in the 2026 Access to Medicine Index, maintaining its lead since 2024 by excelling across all assessed technical areas, including governance, R&D, and product delivery. The company scored 3.86 out of 5 overall, with a...
